Migdal Insurance & Financial Holdings’s Indaptus Therapeutics INDP Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-326	Closed	-$3.17M	–	763
2019 Q2	$3.17M	Buy	326 +67	+26%	+$845K	0.08%	110
2019 Q1	$4.25M	Hold	259	–	–	0.1%	107
2018 Q4	$4.37M	Sell	259 -4	-2%	-$54.5K	0.1%	105
2018 Q3	$3.33M	Buy	263 +30	+13%	+$285K	0.07%	181
2018 Q2	$2.3M	Hold	233	–	–	0.05%	188
2018 Q1	$3.3M	Hold	233	–	–	0.08%	158
2017 Q4	$2.69M	Hold	233	–	–	0.07%	152
2017 Q3	$4.67M	Hold	233	–	–	0.11%	133
2017 Q2	$2.98M	Buy	233 +11	+5%	+$134K	0.07%	123
2017 Q1	$2.54M	Buy	+222	New	+$2.47M	0.06%	120
2016 Q4	–	Sell	-221	Closed	-$2.91M	–	418
2016 Q3	$2.91M	Hold	221	–	–	0.08%	84
2016 Q2	$2.28M	Buy	+221	New	+$1.99M	0.06%	102

Other funds holding INDP

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

ARTA

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Migdal Insurance & Financial Holdings's INDP Position: Q3 2019 in Review

Migdal Insurance & Financial Holdings sold out of Indaptus Therapeutics (INDP) in Q3 2019, closing a stake of 326 shares — an estimated $3.17M sold.

Migdal Insurance & Financial Holdings first reported a position in INDP in Q2 2016 and held it in 12 quarters. The position peaked at $4.67M in Q3 2017. 33 funds tracked by Wall St. Rank hold INDP as of Q3 2019.

Migdal Insurance & Financial Holdings reported no remaining Indaptus Therapeutics position as of Q3 2019 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 326 Indaptus Therapeutics shares in Q3 2019, an estimated $3.17M.
Migdal Insurance & Financial Holdings first reported a position in Indaptus Therapeutics in Q2 2016 and held it in 12 quarters.
Migdal Insurance & Financial Holdings's Indaptus Therapeutics position peaked at $4.67M in Q3 2017.
33 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q3 2019.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q3 2019, filed 12 Nov 2019.